2012 American Thoracic Society Foundation Research Program: Opportunities in Pulmonary Hypertension
These grants are being offered in partnership with the Pulmonary Hypertension Association.
Letter of Intent (LOI) Applications must be submitted through Foundant Technologies on or before Friday July 6, 2012.
ATS/Pulmonary Hypertension Association/Pfizer Research Fellowships in Pulmonary Arterial Hypertension (1 Grant)
This research fellowship has been made possible by funding from the Pulmonary Hypertension Association and Pfizer, Inc. Please visit phassociation.org and Pfizer.com for more information about our partners.
The target audience for this research fellowship will be investigators interested in research in pulmonary arterial hypertension. The fellowship will be directed to supporting research into the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. A primary goal of the PHA Research Program is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. Both US and non-US based investigators are encouraged to apply. At least one of the investigators must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Investigators are also encouraged to connect to the PH medical community through membership in PH Clinicians and Researchers (PHA’s medical association) during the course of their research. Indirect costs will not be paid to the sponsoring institution.
ELIGIBILITY:
A primary goal of the ATS Foundation Research Program is to enable new investigators the chance to make the transition to careers as established investigators. Applicants must have completed their primary research training (PhD or sub-specialty fellowship training) by July 1, 2012 and have a firm commitment from their home institution for a faculty position. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their research training.
At least one of the key personnel must be an ATS member at the time of application, and the principal investigator must be an ATS member at the time that the grant is awarded. Individuals may submit multiple letter of intent (LOI) applications, but ATS will extend at most one invitation to submit a full grant application to each applicant.
Consistent with our intention to support early career investigators, applicants shall not be over 12 years beyond their doctoral degree or equivalent (i.e., MD, PhD, DVM).*
Applicants shall not be the recipients of relatively large national awards defined as an NIH R01, Veterans Affairs Grant, Department of Defense Grant or equivalent awards with funding of ≥ $100,000 per year for at least 2 years from a single grant at any time.*
At the present time, investigators in the following categories are not eligible to apply for ATS grants:
US-based trainees who do not hold a Visa that spans the project period of the grant
Current awardees of the ATS Foundation Research Program
Individuals who have received 2 ATS grants
If you have special extenuating circumstances and that prevent you from meeting these eligibility guidelines, please contact Alyssa Chase, Senior Manager of the ATS Foundation Research Program.
PHA and ATS Fellow Career Development Awards (2 Grants)
This research fellowship has been made possible by funding from the Pulmonary Hypertension Association and the ATS Foundation.
The Fellowship Career Development Awards are designed to support the research of MD and PhD fellows undergoing training in PAH-directed research. The goal is to support the research efforts of fellows during the latter part of their training (typically after their second year of training) in order to enhance their educational experience, advance discovery, and promote careers in academia. The award Mentored projects addressing important areas of investigation in pulmonary medicine, critical care, and sleep-related disorders are encouraged.
Eligibility and Guidelines:
Applicants must hold a MD, DO, MD/PhD, PhD, DVM, or equivalent degree and should plan to pursue a career in academic medicine
Applicants must be enrolled in an accredited pulmonary/critical care training program and must be in good standing in the program
Applicants must be a U.S. citizen or resident alien with a Permanent Resident Card (“Green Card”) at the time the application is submitted.
* Please note that we will accept multiple applications from the same program. However, the intent of this fellowship is to fund only one applicant per program. Exceptions may be made if one of the applications is in pediatric and the other one is in adult pulmonology/critical care.
Conditions of the Award:
Each award is $50,000 for one year.
Awards are not renewable for a second year of funding.
Funds may be used for any combination of salary and/or lab support.
Awards may only be used for direct costs. Institutional indirect or general overhead costs cannot be covered.
Awards must be used for academic career development beyond initial clinical training (typically beyond 2nd year fellowship in pulmonary/critical care fellowship training programs). Individuals who already have faculty positions are not eligible.
During the period of this award, applicants may not accept other training awards or other external funds that provide stipend or salary support for the same work outlined in this application.
INFORMATION FOR ALL AWARDS
Review Process
The ATS Scientific Advisory Committee (SAC) will review the applications. The membership of the SAC is listed on the ATS Website. Additional adhoc reviewers will be invited to participate, as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.
ATS Policy on Additional Grant Funding
Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the ATS within one month of formal notification of award. A subcommittee of SAC will assess degree of overlap. In case of significant scientific overlap the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.
